Westfield Capital Management CO LP Merus N.V. Transaction History
Westfield Capital Management CO LP
- $19.3 Billion
- Q1 2025
A detailed history of Westfield Capital Management CO LP transactions in Merus N.V. stock. As of the latest transaction made, Westfield Capital Management CO LP holds 1,501,220 shares of MRUS stock, worth $82.8 Million. This represents 0.33% of its overall portfolio holdings.
Number of Shares
1,501,220
Previous 993,157
51.16%
Holding current value
$82.8 Million
Previous $41.8 Million
51.3%
% of portfolio
0.33%
Previous 0.19%
Shares
3 transactions
Others Institutions Holding MRUS
# of Institutions
195Shares Held
62.2MCall Options Held
355KPut Options Held
96.5K-
Wellington Management Group LLP Boston, MA4.72MShares$260 Million0.04% of portfolio
-
Commodore Capital LP New York, NY4.47MShares$247 Million18.43% of portfolio
-
Rtw Investments, LP New York, NY4.17MShares$230 Million2.88% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.37MShares$186 Million7.27% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.17MShares$175 Million3.38% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $2.53B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...